Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-02-13
Wolk Joseph J Files Johnson & Johnson (JNJ) Form 4 - February 13, 2026
Wolk Joseph J traded 215.6K JNJ shares worth $34.4M in this Form 4 filing, reported to the SEC on 2026-02-13.
- Insider
- Wolk Joseph J
- Issuer
- Johnson & Johnson JNJ · NYSE
- Filed
- Period
- 2026-02-13
- Accession
- 0000200406-26-000041
- Source
- Official filing on sec.gov ↗
Transactions (15)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Wolk Joseph J | 2026-02-17 | Sell | 12.1K | $242.87 | $2.9M | Direct |
| Wolk Joseph J | 2026-02-17 | Buy | 19.2K | $115.67 | $2.2M | Direct |
| Wolk Joseph J | 2026-02-17 | Sell | 19.2K | $242.99 | $4.7M | Direct |
| Wolk Joseph J | 2026-02-17 | Buy | 12.1K | $129.51 | $1.6M | Direct |
| Wolk Joseph J | 2026-02-17 | Sell | 25.0K | $242.68 | $6.1M | Direct |
| Wolk Joseph J | 2026-02-17 | Sell | 33.4K | $242.75 | $8.1M | Direct |
| Wolk Joseph J | 2026-02-17 | Buy | 33.4K | $131.94 | $4.4M | Direct |
| Wolk Joseph J | 2026-02-15 | Sell | 817 | $243.45 | $198.9K | Direct |
| Wolk Joseph J | 2026-02-15 | Buy | 2.0K | $0.00 | $0.00 | Direct |
| Wolk Joseph J | 2026-02-15 | Sell | 858 | $243.45 | $208.9K | Direct |
| Wolk Joseph J | 2026-02-15 | Buy | 1.9K | $0.00 | $0.00 | Direct |
| Wolk Joseph J | 2026-02-13 | Buy | 37.5K | $0.00 | $0.00 | Direct |
| Wolk Joseph J | 2026-02-13 | Sell | 507 | $244.55 | $124.0K | Direct |
| Wolk Joseph J | 2026-02-13 | Buy | 1.8K | $0.00 | $0.00 | Direct |
| Wolk Joseph J | 2026-02-13 | Sell | 15.9K | $244.55 | $3.9M | Direct |
| Net change | 0 | −$18.0M | ||||
About Johnson & Johnson
Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
Track JNJ insider activity
Get alerted when Johnson & Johnson executives buy or sell their shares.